Adaptimmune Therapeutics PLC (ADAPY) Return on Equity [ROE] (2016 - 2024)
Adaptimmune Therapeutics' Return on Equity [ROE] came in at -154.22% for Q4 2024, up 24.21 percentage points from -178.42% a year earlier but down 103.70 percentage points from the prior quarter.
Powered by 
Analysis
Adaptimmune Therapeutics PLC (ADAPY) Return on Equity [ROE] (2016 - 2024) Analysis & Trends
For FY2024, Adaptimmune Therapeutics' Return on Equity [ROE] was -275.74%, down 88.13 percentage points from FY2023.
- Return on Equity [ROE] has declined in each of the last four years, with a five-year change of -201.71 percentage points (FY2019 to FY2024).
- Going back by year, Return on Equity [ROE] was -187.61% in FY2023 (-72.65 pp), -114.96% in FY2022 (-57.18 pp), -57.78% in FY2021 (-1.81 pp) and -55.97% in FY2020 (+18.07 pp).
- The five-year range for quarterly Return on Equity [ROE] is -511.55% (Q1 2024) to -31.35% (Q3 2020).
- Year-over-year, Return on Equity [ROE] increased in four of the last eight quarters, with an average year-over-year change of -40.24 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2020 (a gain of 64.84 percentage points), and the weakest in Q1 2024 (a drop of 373.81 percentage points).
- Business Quant data shows ADAPY's Return on Equity [ROE] at -50.51% (Q3 2024), -120.18% (Q2 2024) and -511.55% (Q1 2024) in the three quarters before Q4 2024.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -154.22% |
| Sep 30, 2024 | -50.51% |
| Jun 30, 2024 | -120.18% |
| Mar 31, 2024 | -511.55% |
| Dec 31, 2023 | -178.42% |
| Sep 30, 2023 | -88.65% |
| Jun 30, 2023 | -86.47% |
| Mar 31, 2023 | -137.74% |
| Dec 31, 2022 | -169.51% |
| Sep 30, 2022 | -137.17% |
| Jun 30, 2022 | -115.42% |
| Mar 31, 2022 | -92.44% |
| Dec 31, 2021 | -70.74% |
| Sep 30, 2021 | -60.06% |
| Jun 30, 2021 | -50.72% |
| Mar 31, 2021 | -42.96% |
| Dec 31, 2020 | -36.27% |
| Sep 30, 2020 | -31.35% |
| Jun 30, 2020 | -42.69% |
| Mar 31, 2020 | -89.07% |
API Access
Adaptimmune Therapeutics PLC Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ADAPY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ADAPY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ADAPY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();